Article
Pharmacological inhibition of epidermal growth factor receptor attenuates intracranial aneurysm formation by modulating the phenotype of vascular smooth muscle cells.
CNS neuroscience & therapeutics - 1 Jan 2022
Luo Yin, Tang Haishuang, Zhang Zhaolong, Zhao Rui, Wang Chuanchuan, Hou Wenguang, Huang Qinghai, Liu Jianmin
Abstract excerpt
AIM: To study the effect of pharmacological inhibition of epidermal growth factor receptor (EGFR) on intracranial aneurysm (IA) initiation. METHODS: Human IA samples were analyzed for the expression of p-EGFR and alpha smooth muscle actin (α-SMA) by immunofluorescence (IF). Rat models of IA were established to evaluate the ability of the EGFR inhibitor, erlotinib, to attenuate the incidence of IA. We analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
